Afynia

Afynia, formerly known as AIMA Laboratories, is a Canadian diagnostics company developing a blood-based test to help identify endometriosis, a condition that affects roughly 1 in 10 women of reproductive age and often takes 5 to 12 years to diagnose. The company's four-step process — physician consultation, blood draw, laboratory microscopy analysis, and a personalized health plan — aims to give patients and physicians faster clarity on chronic pelvic pain, painful periods, and infertility linked to endometriosis. Afynia's mission is to shorten the diagnostic delay that leaves many women without answers for their symptoms.